Arvinas, Inc. (ARVN): Price and Financial Metrics
ARVN Price/Volume Stats
| Current price | $8.75 | 52-week high | $43.07 |
| Prev. close | $9.00 | 52-week low | $7.91 |
| Day low | $8.51 | Volume | 3,239,200 |
| Day high | $8.88 | Avg. volume | 1,754,245 |
| 50-day MA | $16.28 | Dividend yield | N/A |
| 200-day MA | $22.95 | Market Cap | 601.76M |
ARVN Stock Price Chart Interactive Chart >
Arvinas, Inc. (ARVN) Company Bio
Arvinas Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer. The company is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases, including tauopathies. Arvinas Holding Company, LLC was founded in 2015 and is based in New Haven, Connecticut.
ARVN Price Returns
| 1-mo | -50.76% |
| 3-mo | -53.28% |
| 6-mo | -63.02% |
| 1-year | -79.12% |
| 3-year | -86.46% |
| 5-year | -78.56% |
| YTD | -54.36% |
| 2024 | -53.43% |
| 2023 | 20.32% |
| 2022 | -58.35% |
| 2021 | -3.29% |
| 2020 | 106.69% |
Continue Researching ARVN
Here are a few links from around the web to help you further your research on Arvinas Inc's stock as an investment opportunity:Arvinas Inc (ARVN) Stock Price | Nasdaq
Arvinas Inc (ARVN) Stock Quote, History and News - Yahoo Finance
Arvinas Inc (ARVN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...